G-NiiB GenieBiome 精進微生物科技有限公司
@geniebiome.com
G-NiiB® is the registered trademark of GenieBiome Limited. GenieBiome, a biotechnology spinout from The Chinese University of Hong Kong was founded by world-renowned clinician-scientists and supported by a multidisciplinary team of experts in microbiology, metagenomics, bioinformatics, disease biomarkers, food technology, clinical trials, IP development and commercialization. For over a decade, our team has pioneered the use of microbiome with evidence-based science to tackle a myriad of diseases, including COVID-19, colorectal cancer, obesity, eczema, and autism. Our precision portfolio of G-NiiB includes diagnostic and risk prediction tests, next-generation microbiome precision formula, and precision medicine tailored for the Asian population. ------------ G-NiiB® 是精進微生物科技有限公司 GenieBiome Ltd 及其子公司的註冊商標。 G-NiiB 是一家由香港中文大學衍生出來的生物科技公司，由世界知名的臨床醫生科學家創立，並由微生物學，宏基因組學，生物信息學，疾病生物標誌物，食品技術，臨床試驗，知識產權開發和商業策略的多學科專家團隊提供支持。十多年來，我們團隊率先從科學論證微生物群的應用，以應對多種疾病，包括COVID-19，結直腸癌，肥胖，濕疹和自閉症。我們的精準微生態診斷及風險測試、精準微生態平衡配方、新一代天然活菌及治療，專為亞洲人而設。
G-NiiB GenieBiome 精進微生物科技有限公司's Company Logos
G-NiiB GenieBiome 精進微生物科技有限公司's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1DB9BF
Java
29, 185, 191
182, 74, 43
85, 3, 0, 25
#FAE274
Marigold Yellow
250, 226, 116
49, 93, 72
0, 10, 54, 2
#002D4D
Prussian Blue
0, 45, 77
205, 100, 15
100, 42, 0, 70
About G-NiiB GenieBiome 精進微生物科技有限公司
GenieBiome is a leading brand that aims to improve health and tackle various conditions such as COVID-19, colorectal cancer, obesity, hyperlipidemia, autism, eczema, and hair loss. Established by a team of internationally renowned professors and clinician-scientists from The Chinese University of Hong Kong, GenieBiome is at the forefront of gut microbiome research with cutting-edge technologies and strong academic standing. With the understanding that 90% of our bodies are dominated by microbes, GenieBiome pioneers the use of novel microbes as diagnostic markers and potential remedies for different diseases.
They have developed proprietary machine-learning algorithms and utilized unique in-house and publicly available datasets to accurately predict disease risk. GenieBiome's focus is on transforming novel microbiome signatures into groundbreaking diagnostics and effective therapeutics. Their pipeline includes innovative approaches and solutions for both diagnostics and therapeutics.
They have a dedicated team of medical advisors and continuously contribute to scientific advancements with their publications, videos, and news updates. In the pursuit of improving health, GenieBiome offers a comprehensive range of science-driven products and services that revolutionize the field of gut microbiome research
Company type
Privately Held
Year founded
2020
Company size
11-50 employees
